Aditxt, Inc. (ADTX): Shareholders' Equity
$5.61M
As of 2025-12-31
-$33.28M
As of 2026-03-31
+2.5%
3-year compound annual growth
-12.6%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.61M | +235.0% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $1.67M | -89.6% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $16.06M | +208.4% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $5.21M | -48.9% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $10.18M | -7.5% | 2023-04-17, Balance as of period end |
| 2020-12-31 | $11.01M | n/m | 2022-03-31, Balance as of period end |
| 2019-12-31 | -$2.85M | n/a | 2021-03-25, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | 2025-12-31 | $5.61M | +235.0% |
| One World Products, Inc. (OWPC) | 2024-12-31 | -$9.91M | n/m |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $2.15M | +4.4% |
| Aspire-Lakewood Holdings, Inc. (ASBP) | 2025-12-31 | -$6.38M | n/m |
| Genelux Corp (GNLX) | 2025-12-31 | $11.54M | -56.1% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $8.54M | +368.4% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | -$2.13M | n/m |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | -$10.26M | n/m |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | -$1.83M | n/m |
Compare ADTX, OWPC, TCRT, ASBP side by side · Screen every company in Pharmaceutical Preparations ↗